Make your money go further for just 25p per day

Microsaic Systems plc (AIM: MSYS) – supply agreement signed with GE Healthcare 

16/03/2015 · Microsaic Systems plc (MSYS) 

Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments today announced it has signed an OEM (original equipment manufacturer) supply agreement with GE Healthcare, for the sale of its 4000 MiD® unit in combination with GE Healthcare's instruments. 

Microsaic Systems develops and sells chip-based scientific instruments for the chemical identification of substances. The Company’s products are based on the ‘gold-standard’ scientific technique of mass spectrometry.

Mass spectrometry (MS) is an analytical chemistry technique that helps identify the amount and type of chemicals present in a sample by measuring the mass-to-charge ratio and abundance of gas-phase ions.

Mass spectrometry is used across many industry sectors, including government, energy, utilities, pharmaceutical, diagnostics and…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Microsaic Systems plc

Microsaic Systems plc (AIM: MSYS) – positive financial results and end of year trading update

23/03/2015 · Company Insights
Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments, today announced its preliminary results…

Microsaic Systems plc (AIM: MSYS) – supply agreement signed with GE Healthcare 

16/03/2015 · Company Insights
Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments today announced it has signed…

More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP